| |
 |
|
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6960568 |
Nucleosides and related processes, pharmaceutical compositions and methods |
Nov. 1, 2005 |
| 6958239 |
Three component chimeric antisense oligonucleotides |
Oct. 25, 2005 |
| 6956117 |
Self-replicating RNA molecule from hepatitis C virus |
Oct. 18, 2005 |
| 6953783 |
Modulation of gene expression by combination therapy |
Oct. 11, 2005 |
| 6949378 |
C. elegans gro-1 gene |
Sep. 27, 2005 |
| 6949379 |
Aptamer-mediated regulation of gene expression |
Sep. 27, 2005 |
| 6949380 |
Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
Sep. 27, 2005 |
| 6949624 |
Cloning of the human nuclear receptor co-repressor gene |
Sep. 27, 2005 |
| 6946246 |
Production of functional proteins: balance of shear stress and gravity |
Sep. 20, 2005 |
| 6946447 |
MDM2-specific antisense oligonucleotides |
Sep. 20, 2005 |
| 6943022 |
Inhibition of apoptosis by the expression of antisense RNA of caspase-3 |
Sep. 13, 2005 |
| 6939711 |
Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
Sep. 6, 2005 |
| 6940001 |
Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein |
Sep. 6, 2005 |
| 6936593 |
Method of down-regulating gene expression |
Aug. 30, 2005 |
| 6930226 |
Granule-bound starch synthase |
Aug. 16, 2005 |
| 6924096 |
Delivery construct for antisense nucleic acids and methods of use |
Aug. 2, 2005 |
| 6921816 |
Chimerical peptide-nucleic acid fragment, process for producing the same and its for appropriately introducing nucleic acids into cell organelles and cells |
Jul. 26, 2005 |
| 6916653 |
Ribozymal nucleic acid |
Jul. 12, 2005 |
| 6914148 |
Guanidinium functionalized intermediates |
Jul. 5, 2005 |
| 6906186 |
Antisense modulation of polo-like kinase expression |
Jun. 14, 2005 |
| 6900018 |
Method of screening for a biological response using linear and circular expression elements |
May. 31, 2005 |
| 6900053 |
Antisense modulation of fibroblast growth factor receptor 2 expression |
May. 31, 2005 |
| 6900186 |
Method for the prophylaxis and/or treatment of medical disorders |
May. 31, 2005 |
| 6900306 |
Antisense modulation of CoREST expression |
May. 31, 2005 |
| 6900307 |
2-aminopurine derivatives |
May. 31, 2005 |
| 6900368 |
Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
May. 31, 2005 |
| 6897016 |
Alteration of sequence of a target molecule |
May. 24, 2005 |
| 6897019 |
Methods for treating and preventing insulin resistance and related disorders |
May. 24, 2005 |
| 6897024 |
Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
May. 24, 2005 |
| 6897359 |
Carnation antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
May. 24, 2005 |
| 6893821 |
Agents that modulate DNA-PK activity and methods of use thereof |
May. 17, 2005 |
| 6890908 |
Modified ribozymes |
May. 10, 2005 |
| 6887855 |
Forms of 5-azacytidine |
May. 3, 2005 |
| 6887906 |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
May. 3, 2005 |
| 6884430 |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
Apr. 26, 2005 |
| 6884619 |
Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
Apr. 26, 2005 |
| 6884787 |
Antisense modulation of transforming growth factor-beta 3 expression |
Apr. 26, 2005 |
| 6884880 |
Process for the preparation of 9-.beta.-anomeric nucleoside analogs |
Apr. 26, 2005 |
| 6878547 |
Antisense oligonucleotides against tenascin for treating vitiligo |
Apr. 12, 2005 |
| 6875747 |
Antisense to c-myc for treatment of polycystic kidney disease |
Apr. 5, 2005 |
| 6875749 |
Methods of facilitating vascular growth |
Apr. 5, 2005 |
| 6875906 |
Control of sporocyte or meiocyte formation in plants |
Apr. 5, 2005 |
| 6872816 |
Nucleic acid detection kits |
Mar. 29, 2005 |
| 6869780 |
Nodavirus-like DNA expression vector and uses therefor |
Mar. 22, 2005 |
| 6869795 |
Antisense compositions and cancer-treatment methods |
Mar. 22, 2005 |
| 6870046 |
Antisense modulation of interferon gamma receptor 2 expression |
Mar. 22, 2005 |
| 6867039 |
Antisense modulation of dual specific phosphatase 5 expression |
Mar. 15, 2005 |
| 6867043 |
Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells |
Mar. 15, 2005 |
| 6867294 |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages |
Mar. 15, 2005 |
| 6858715 |
Process for the synthesis of oligomeric compounds |
Feb. 22, 2005 |
|
|
|
